Us Bancorp \De\ Bioventus Inc. Transaction History
Us Bancorp \De\
- $77.3 Billion
- Q3 2024
A detailed history of Us Bancorp \De\ transactions in Bioventus Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 9,267 shares of BVS stock, worth $97,674. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,267
Previous 9,267
-0.0%
Holding current value
$97,674
Previous $53,000
107.55%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BVS
# of Institutions
141Shares Held
45.8MCall Options Held
179KPut Options Held
124K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$137 Million44.65% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$73.1 Million33.68% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.35MShares$45.9 Million3.09% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$25 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.07MShares$21.9 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $650M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...